04.07.2012 • NewsLindeLinde EngineeringPetrochemicals

Linde to Built LAO Plant for NKNH

Linde Engineering, a division of the Linde Group, is set to build a new Alpha-Sablin plant for the production of linear alpha olefins (LAO) in Nizhnekamsk, Russian Federation, which upon completion will be operated by Nizhnekamskneftekhim (NKNH), a Russian petrochemical producer.

NKNH awarded Linde Engineering contracts for license, basic/detail engineering and supply of equipment and materials for revamping of NKNH's existing LAO plant.

The plant is expected to come on-stream by mid of 2014, supplying NKNH with 37.5 kta linear alpha olefins with maximized production of C4 and C6 fractions. The revamp project will partially make use of the existing equipment of NKNH's former LAO plant with implementation of Alpha-Sablin technology.

Alpha-Sablin is a flexible full range process for the production of linear alpha olefins by selective catalytic oligomerization of polymer grad ethylene, jointly developed and owned by Linde Engineering and Saudi Basic Industries Corporation (SABIC).

The first full scale Alpha-Sablin plant with a capacity of 150 kta linear alpha olefins was built in 2009 for Jubail United Petrochemical Company (UNITED) in Al Jubail, Kingdom of Saudi Arabia.

 

 

 

 

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.